Parametrica Management’s Pfizer PFE Stock Holding History

Parametrica Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-74,599	Closed	-$3.82M	–	41
2022 Q4	$3.82M	Buy	74,599 +60,385	+425%	+$2.9M	7.84%	2
2022 Q3	$623K	Sell	14,214 -88,592	-86%	-$4.3M	1.27%	27
2022 Q2	$5.4M	Sell	102,806 -32,309	-24%	-$1.65M	5.88%	2
2022 Q1	$7M	Buy	+135,115	New	+$7.01M	5.18%	1
2021 Q1	–	Sell	-9,053	Closed	-$333K	–	216
2020 Q4	$333K	Sell	9,053 -22,651	-71%	-$831K	0.21%	95
2020 Q3	$1.1M	Buy	+31,704	New	+$1.11M	2.08%	15
2018 Q1	–	Sell	-7,328	Closed	-$252K	–	369
2017 Q4	$252K	Sell	7,328 -5,062	-41%	-$173K	0.16%	271
2017 Q3	$420K	Buy	+12,390	New	+$398K	0.18%	112
2017 Q2	–	Sell	-7,732	Closed	-$251K	–	347
2017 Q1	$251K	Buy	+7,732	New	+$244K	0.26%	194

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Parametrica Management's PFE Position: Q1 2023 in Review

Parametrica Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 74,599 shares — an estimated $3.82M sold.

Parametrica Management first reported a position in PFE in Q1 2017 and held it in 9 quarters. The position peaked at $7M in Q1 2022. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Parametrica Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Parametrica Management sold 74,599 Pfizer shares in Q1 2023, an estimated $3.82M.
Parametrica Management first reported a position in Pfizer in Q1 2017 and held it in 9 quarters.
Parametrica Management's Pfizer position peaked at $7M in Q1 2022.
3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Parametrica Management's 13F filing for Q1 2023, filed 9 May 2023.